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Abstract  
The locus coeruleus (LC) supplies norepinephrine (NE) to the entire forebrain, regulates many 
fundamental brain functions, and is implicated in several neuropsychiatric diseases. Although selective 
manipulation of the LC is not possible in humans, studies have suggested that strong LC activation might 
shift network connectivity to favor salience processing. To test this hypothesis, we use a mouse model 
to study the impact of LC stimulation on large-scale functional connectivity by combining chemogenetic 
activation of the LC with resting-state fMRI, an approach we term “chemo-connectomics”. LC 
activation rapidly interrupts ongoing behavior and strongly increases brain-wide connectivity, with the 
most profound effects in the salience and amygdala networks. We reveal a direct correlation between 
functional connectivity changes and transcript levels of alpha-1, alpha-2, and beta-1 adrenoceptors 
across the brain, and a positive correlation between NE turnover and functional connectivity within 
select brain regions. These results represent the first brain-wide functional connectivity mapping in 
response to LC activation, and demonstrate a causal link between receptor expression, brain states and 
functionally connected large-scale networks at rest. We propose that these changes in large-scale 
network connectivity are critical for optimizing neural processing in the context of increased vigilance 
and threat detection. 
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INTRODUCTION 
 
The locus coeruleus (LC) is a small structure in the brainstem (with approximately 1500 neurons 
in each hemisphere in mice and 20'000 in humans)1,2, which sends widespread efferent projections to 
almost the entire brain, and constitutes the major source of norepinephrine (NE) to most forebrain 
regions. Dysregulation of the LC-NE system has been implicated in numerous psychiatric pathologies 
including depression, anxiety, attention-deficit-hyperactivity disorder, post-traumatic stress disorder 
and neurodegenerative diseases3–8. The ability to selectively change activity within the LC-NE system 
with optogenetic and chemogenetic manipulations has confirmed that the LC has a strong modulatory 
effect on various functional circuits related to wakefulness9, cognitive performance and memory6,10–13, 
and on stress-related behavioral responses including fear, anxiety and avoidance3,5,14–19. These 
widespread functional effects are in line with theories that the LC optimizes cognitive processes relevant 
for task performance or adaptive behaviors by rearranging neural activity within and between large-
scale neuronal systems1,20–23. 
Phasic LC activation, as triggered by salient stimuli, enhances cognitive performance and 
facilitates faster orienting towards (and processing of) task-relevant cues1,20,24. In contrast, high tonic LC 
activity, as reliably and robustly triggered by various stressors, causes the release of substantial 
quantities of NE throughout the brain25,26, which is thought to have a "circuit breaker" function that 
allows the interruption of ongoing neural activity and rapid reconfiguration of functional communication 
between brain regions (i.e. functional networks)20,26,27. This rapid response is highly evolutionarily 
conserved,  as it benefits survival by enhancing vigilance and enabling the selection of adaptive 
behaviors in threatening situations28. However, it has not been demonstrated directly that increased LC 
activity reconfigures functional neural networks across the brain, and it remains unknown how the 
widespread LC projections might achieve specificity for regulating specific networks. Some evidence 
suggests that strong LC activation by environmental cues, as observed during acutely stressful situations, 
plays an important role in activating networks that favor salience processing and action selection20,29, 
and that regional specificity is achieved through the distribution of adrenergic receptors26. In humans, 
acute stress exposure dynamically shifts large-scale network activity towards higher activation of the 
salience network (including amygdala)30, which is mediated by beta-adrenergic receptors31 and is 
thought to promote hypervigilance and threat detection at the cost of executive control27,29. However, 
direct involvement of the LC has not been proven, since it is impossible to selectively manipulate LC 
activity in humans.  
To explore whether LC activation changes local and global network organization, we used a 
translational mouse model and applied a novel ‘chemo-connectomics’ approach, which combines (i) 
cell-specific chemogenetic manipulation of neural activity afforded by Designer Receptors Exclusively 
Activated by Designer Drugs (DREADDs)32; with (ii) a brain-wide functional connectome analysis as 
revealed by resting state functional magnetic resonance imaging (rs-fMRI) in mice. This approach 
leverages the molecular tools and genome-wide resources available in mice and allows us to link 
functional connectivity with micro- and mesoscopic properties of the mouse brain. We asked (1) whether 
a selective increase of LC activity would change the functional connectivity profiling of large-scale 
brain networks or “connectome”, (2) if such network-wide effects are related to the known distribution 
of adrenergic receptor subtypes across the brain, and (3) whether changes in functional connectivity 
correspond to the levels of NE release in the target structures.  
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RESULTS 
 
To selectively target the LC, we used transgenic mice that express codon-improved Cre-
recombinase (iCre) under the dopamine-beta-hydroxylase (DBH) promoter (DBH-iCre mice, Figure 
1A)33. We stereotactically delivered floxed excitatory DREADDs34 (AAV5-hSyn-DIO-hM3Dq-
mCherry; hM3Dq-mCh) or a control virus (AAV5-hSyn-DIO-mCherry; mCh) to the LC, thus restricting 
virus expression to DBH-positive noradrenergic neurons of the LC (Figure 1B). We assessed successful 
LC activation using pupillometry, a highly sensitive and clinically relevant readout of LC activation35–
37. After two minutes of baseline recording under light isoflurane anesthesia, we activated LC neurons 
by administering the potent DREADD activator clozapine at an ultra-low dose (0.03 mg/kg, i.p., Figure 
1C)38. Within a minute of clozapine injection, we observed a strong increase in pupil diameter in the 
hM3Dq-mCh group, while pupil diameter of mCh mice did not change in response to clozapine injection 
and remained stable throughout the 10-minute recording session (Figure 1D-F). To show that our LC 
activation protocol is behaviorally relevant, we subjected mice to an open field test (OFT) immediately 
after clozapine injection and recorded their behavior for 30 minutes. In comparison to mCh mice, 
clozapine injection had profound effects on the behavior of hM3Dq-mCh mice. Several minutes after 
clozapine administration, hM3Dq-mCh mice showed strongly suppressed locomotor activity (Figure 
1G, H), spent less time in the (more aversive) center of the open field (Figure 1I, J), performed less 
activity-related supported rears (Figure 1K, L) and less exploratory unsupported rears (Figure 1M, 
N)39. This is in line with previous findings that LC activation suppresses motor activity9,16 and increases 
anxiety3,14,16. Because the LC is a highly sexually dimorphic structure, we assessed whether these 
findings hold true in female mice as well. We confirmed that after clozapine administration, hM3Dq-
mCh females also showed reduced locomotor activity in the OFT (Figure S1B, C), spent less time in 
the center (Figure S1D, E), and performed fewer supported (Figure S1F, G) and unsupported rears 
(Figure S1H, I). To better characterize the effects of LC activation on behavior, we also tested these 
females in the light-dark box (LDB) for 30 minutes, immediately after clozapine injection (Figure S1A). 
Compared to mCh, hM3Dq-mCh mice spent much less time in the aversive light compartment of the 
box (Figure S1J, K), and more time in the dark compartment (Figure S1L, M). They also travelled less 
distance (Figure S1N, O), shuttled fewer times between the light and the dark compartment (Figure 
S1P), and performed fewer rears (Figure S1Q, R). These results indicate reduced exploratory behavior 
and increased anxiety. As the strong suppression of locomotor activity could also be due to locomotor 
impairment, we trained the same mice on the rotarod (Day 1), and then tested them on two consecutive 
days, without clozapine (Day 2) or with clozapine (Day 3, see Figure S1A). Both during training and 
testing, hM3Dq-mCh mice performed similarly before and after clozapine injection (Figure S1S), with 
no significant difference between groups or across daily trials (Figure S1T, S1U). Thus, the strong 
suppression in locomotor activity after LC activation is likely due to an increase in anxiety and not due 
to any gross locomotor impairment.  
Next, we validated activation of LC neurons molecularly. To this end, we returned to the same 
male mice that were used for OFT testing and injected them again with clozapine, collected their brains 
90 minutes later and assessed the neural activity marker cFos in the LC using immunohistochemistry. 
As expected, we observed a strong increase in cFos expression restricted to tyrosine hydroxylase-
positive (TH+) noradrenergic neurons of the LC in hM3Dq-mCh mice, whereas cFos was virtually 
absent in mCh mice (Figure 1O, P). Because behavior testing and cFos staining were performed in the 
same mice, we correlated the locomotor activity of hM3Dq-mCh mice with the number of cFos-positive 
neurons in the LC. We found a strong negative correlation (Figure 1Q), showing that the strength of 
LC activation predicts the suppression in locomotion/exploration. Thus, our chemogenetic strategy 
specifically activates LC neurons and rapidly induces behavioral changes that last at least 30 minutes.  
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  Figure 1. Physiological, 
behavioral and molecular 
effects of LC activation with 
hM3Dq. (A) Schematic of  
DBH-iCre mouse genetics. (B) 
mCherry (mCh) co-localizes 
with tyrosine hydroxylase 
(TH) in the LC of DBH-iCre 
mice after stereo-tactic 
delivery of AAV5-Syn1-DIO-
mCh. (C) Diagram of the 
experimental design. (D) 
Images showing the pupil size 
before and after administration 
of clozapine in a mouse 
expressing hM3Dq-mCh in 
LC. (E, F) Pupil size increased 
after clozapine administration 
only in hM3Dq-mCh mice 
(interaction time x group: 
F(1,10)=9.60, p=0.0113, two-
way ANOVA with Sidak post 
hoc tests). (G-N) Immediately 
after clozapine injection, 
hM3Dq-mCh mice travelled 
less distance than mCh control 
mice (G, H: main effect of 
group: F(1,10)=21.92, 
p=0.0009, two-way ANOVA), 
spent less time in the center (I, 
J: main effect of group 
F(1,10)=5.15, p=0.0467; 
interaction: F(9,90) =3.04, 
p=0.0032, two-way ANOVA 
with Sidak post hoc tests), per-
formed fewer supported rears 
(K, L: main effect of group: 
F(1,10)=7.24, p=0.0227) and 
fewer unsupported rears (M, 
N: main effect of group: 
F(1,10) =11.33, p=0.0072, 
interaction: F(9,90)=2.46, 
p=0.0148). (O) Representative 
images of cFos expression in 
TH+ neurons in the LC of 
hM3Dq-mCh or mCh mice, 90 
minutes after injection of 
clozapine. (P) Quantification 
of cFos expression showing 
increased neuronal activation 
in hM3Dq-mCh mice 
(t(10)=5.12, p=0.0005, 
unpaired t test). (Q) cFos 
expression in LC correlates 
with distance travelled in the 
OFT in hM3Dq-mCh mice 
(r(5)=-0.8782, p=0.0093). 
hM3Dq-mCh (n=7), mCh 
(n=5). *=p<0.05, **=p<0.01, 
***=p<0.001. Data represent 
mean ± SEM. All scale bars: 
50 μm. 
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LC activation drives rapid increases in functional connectivity  
We hypothesized that an increase of LC-NE activity would rapidly reconfigure large-scale brain 
networks as reflected by the functional connectome. We therefore acquired resting state-fMRI (rs-fMRI) 
data before and after hM3Dq-induced LC activation in a continuous imaging session. We kept mice 
under light isoflurane anesthesia (see methods) and recorded 15 min of baseline fMRI, before activating 
hM3Dq with clozapine (0.03 mg/kg, i.v.)40. After the clozapine injection, we continued the fMRI 
recordings for 8 minutes (i.e. transitory period) followed by another 15 minutes where LC is expected 
to be robustly activated (i.e. active period), leading to a total uninterrupted scan time of 38 minutes 
(Figure 2A). Although a sustained increase in neural activity can be shown for at least two hours after 
hM3Dq-DREADD activation38, we limited the duration of the functional imaging session to reduce the 
accumulation of isoflurane over time, which might otherwise impact the local excitation-inhibition 
balance and neurovascular coupling41.  
We first tested whether the observed changes in whole-brain connectivity were time-locked to 
DREADD activation in hM3Dq-mCh mice, but not mCh mice. We measured functional connectivity 
(FC) between 165 brain regions using the Allen’s Common Coordinate Framework, and within 38 non-
overlapping bins of 1 minute. For each bin, FC is measured between each pair of regions and normalized 
to the subject’s baseline connectivity (i.e. averaged across the first 15 minutes), and the effect size is 
calculated using the standardized difference between the group means (Cohen’s D, hM3Dq-mCh vs 
mCh). During the first 15 minutes (baseline) Cohen’s D varied on average between -0.12 and +0.10 
(average: -0.00, null-to-small effect), and did not demonstrate an appreciable spatial or temporal pattern. 
However, immediately after clozapine injection, the effect size rapidly and significantly increased for 
the remainder of the scan session, showing increased connectivity in hM3Dq mice relative to mCh 
controls (Figure 2B, C). Effect sizes range on average from +0.21 to +0.38 (moderate effect) and up to 
+3.2 for individual edges (very strong effect). These findings show that changes observed in the 
connectome are temporally linked to the activation of the LC-NE system and occur within minutes after 
intravenous injection of clozapine in mice expressing hM3Dq. 
 
Increased functional connectivity is dependent on LC-NE signaling 
We next tested whether the DREADD-induced connectivity changes could be 
pharmacologically blocked by medetomidine, a selective agonist of the inhibitory adrenergic alpha-2 
receptor. Through alpha-2 autoreceptors, medetomidine suppresses LC firing and NE release42,43. After 
pre-treating mice with a bolus injection of medetomidine (0.05 mg/kg, i.v.), medetomidine was also 
continuously infused at 0.1 mg/kg/h i.v. to maintain its levels stable throughout the ensuing rs-fMRI 
session, as previously described44. After 15 minutes of baseline recording, clozapine was again 
administered as described above (Figure 2A). Across all edges, Cohen’s D did not vary significantly 
over-time, showing that medetomidine prevented DREADD-induced LC activation (Figure 2D, E).  
To examine the effect of different anesthesia regimes on FC over-time, we compared the effect 
size in mCh mice between both anesthesia conditions (i.e. 1% isoflurane vs. 0.5% 
isoflurane+medetomidine). We found no significant differences between the two experimental 
conditions in the baseline and transient periods (Figure S2). However, Cohen’s D was slightly increased 
in the active period, suggesting a reduction of connectivity across all edges in the isoflurane group. This 
is a well-known effect, most likely caused by the accumulation of isoflurane over-time45. The net effect 
was, however, null-to-small (average: +0.04, min: -0.04, max: +0.129) and about 7 times smaller than 
the DREADD-driven effect. Collectively, our findings indicate that the substantial changes in 
connectivity after DREADD activation causally depend on activation of the LC-NE system, as they are 
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Spatial reconfiguration of the functional connectome after LC activation reflects transcript levels 
of adrenoceptors 
Next, we mapped the location of the connections that were altered following LC activation. To 
this end, we compared the connectome matrix obtained from the first 15 minutes of the scan (baseline 
period) to the last 15 minutes of the scan (post clozapine, 'active period'). The analysis of the functional 
connectome after LC-NE activation revealed a large group of edges that display increased FC in the 
hM3Dq-mCh animals compared to mCh after clozapine injection (218 edges, time × group interaction, 
non-parametric, randomized permutation testing, family-wise error (FWE) corrected with Network 
Based Statistics at p<0.05) (Figure 3A). The spatial distribution of these hyper-connected edges is 
widespread and involves 64% of the 165 brain regions considered in the analysis (105 ROIs) (Figure 
3B), which is in line with the widespread afferent fibers originating from the LC46,47.  
We quantitatively ranked the brain regions based on how LC activation changed the strength of 
its connections. To do this, we derived a surrogate ‘node modulation index’ (NMI) by measuring the 
averaged effect size for any brain region in the connectome matrix (Figure 3C). Note that only the top-
Figure 2. DREADD activation of the LC causes time-locked changes in functional connectivity. (A) 
Schematic of the experimental set-up for MRI recordings. 4 weeks after bilateral virus delivery, mice 
underwent two MRI sessions with the same experimental procedure but different anesthetic regimes. Effect-
size (Cohen’s D) analysis of Functional Connectivity (FC) is shown for single-edges (n=2724) (B) and for the 
average across all edges (C). The data reveal time-locked increases in connectivity in multiple edges, starting 
immediately after clozapine (0.03 mg/kg) i.v. injection (Wilcoxon two-tailed test: p=0.804 for baseline period, 
p=0.015 for transient period and p<0.0001 for active period). (D, E) Treatment with the alpha-2 adrenergic 
agonist medetomidine (0.05 mg/kg + 0.1mg/kg/h, see methods) abolishes clozapine-induced effects between 
hM3Dq-mCh and mCh groups (Wilcoxon two-tailed test: p=0.805 for baseline period, p=0.937 for transient 
period, and p=0.978 for active period). *=p<0.05, ****=p<0.0001, NS=not significant. hM3Dq-mCh (n=11), 
mCh (n=7). 
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10% of the connectome edges, based on FC strength at baseline, were considered in the analysis (see 
Figure S3A-C for a more detailed evaluation of other sparsity levels). The NMI varied across the brain 
(Figure 3D, E, full list in supplementary table 1). The strongest variations occurred in regions that are 
densely innervated by the LC, such as the primary sensory and somatomotor areas48, the claustrum49, 
the prefrontal cortex (notably the agranular insular cortex; pre- and infralimbic cortices; the frontal pole; 
and anterior cingulate areas)16,26, several nuclei of the amygdala15 ,the thalamus19, and the association 
cortex26 (Figure 3D, E).  
The LC is a bilateral structure, and each locus primarily projects ipsilateral. Thus, we tested 
whether our LC stimulation would similarly affect the spatial patterns of FC within the left and the right 
hemispheres. We found remarkably similar changes in FC (Figure S4) on each side. The distribution of 
the effect size for all edges is right-skewed in both left and right hemispheres (Figure S4A, B), 
demonstrating increased connectivity after LC activation. Further, the changes in each node expressed 
with the NMI were highly linearly correlated between left and right hemisphere (Pearson’s correlation 
= 0.7764, p<0.0001, Figure S4C). 
We then took advantage of the unique availability of molecular data in the same mouse strain, 
and asked if the anatomical heterogeneity found in the connectivity-based NMI maps relates to the 
spatial distribution of adrenergic receptors in the mouse brain. Gene transcript maps of adrenoceptors 
alpha-1 (subunits a-d), alpha-2 (subunits a-c), beta-1 and beta-2 were obtained from the Allen Mouse 
Brain Atlas50. The similarity with NMI maps was quantified using the Spearman rank correlation 
coefficient (Rho) across all 165 brain areas of the Allen’s Common Coordinate Framework. After 
correcting for testing multiple independent hypotheses, we found that the transcriptional maps of all 
adrenoceptors display a significant correlation with the NMI, with the exception of beta-2 adrenergic 
receptors (Figure 4A-D). All these correlations display a higher than chance Spearman’s rho value 
(p<0.0001 against a null distribution generated using 10.000 random permutations). We additionally 
compared our MNI maps against all dopamine (D1, D2, D3, D4, D5) and serotonin (Htr1, Htr2, Htr3, 
Htr4, Htr5, Htr6, Htr7) receptors, to assess the specificity of our results. We found a significant 
Spearman’s correlation with both D1 (ρ=0.4014, pFDR=1.18e-7) and D4 (ρ=0.3805, pFDR=1.37e-6) 
receptors, which survived permutation testing and FDR correction, but not with D2, D3 and D5 (Figure 
S5). None of the serotonin receptors had correlations higher than chance (Figure S6). These results 
represent the first brain-wide FC mapping in response to LC activation, revealing an anatomically 
specific connectomic fingerprint of LC hyperactivity, which maps well onto the spatial distribution of 
specific adrenoceptors and dopamine receptors.  
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Figure 3. A whole-brain map showing the connectome after DREADD-induced LC activation. (A) 
Randomized non-parametric statistics report a drastic shift toward hyper-connectivity in the hM3D(Gq)-mCh 
group after clozapine injection (15 min bins). (B) Circos-plot showing the anatomical location of hyper-
connected edges in response to LC activation (p<0.05, Network Based Statistics, FWE corrected). (C) Node 
Modulation Index (NMI), calculated as the averaged effect-size in each brain area (165 ROIs, based on the 
Allen Common Coordinate Framework). (D) Rendering of NMI in Allen MRI space, revealing a 
heterogeneous distribution across brain regions. (E) Bar plots representing all the ROIs with an NMI > 0.5 
(moderate-to-strong effect). Full ROI list in Supplementary Table 1. 
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LC increased connectivity within large-scale resting-state networks  
Thus far, our data driven analyses were focused on changes in connectivity between 
anatomically-defined pairs of brain regions. Next, we examined whether LC activation prompts large-
scale resting-state network (RSN) reconfiguration, by calculating the spatial extent and connectivity 
strength in thirteen maximally-independent RSNs. These RSNs were obtained from an independent 
cohort of wild-type mice using a data-driven probabilistic independent component analysis (ICA), 
followed by an estimation of network coupling strength at the voxel level using a dual regression 
approach51 (for a complete list and spatial distribution of the networks please refer to our previous 
study52). Statistical analyses were conducted both at the voxel level (using non-parametric permutation 
testing with Threshold-Free Cluster Enhancement to correct for multiple comparisons which allows 
voxel-wise inference), and by measuring a connectivity-strength index within each RSNs (using a Linear 
Mixed-Model, see52).   
In 6 out of 13 RSNs, we found significant group x time interactions resulting from an increase 
of within-network connectivity in the hM3Dq-mCh group, which was in stark contrast to the slight 
decrease in connectivity observed in the mCh group (Figure 5). The latter effect is likely attributable to 
an accumulation of isoflurane over time45 (see Figure S2) which is, however, clearly reversed upon LC 
Figure 4. Functional connectivity changes after LC-NE activation spatially correlate with adrenoceptor 
gene expression. Spearman correlation coefficients, Rho, and associated p-value (FDR corrected) between 
Node Modulation Index and the transcriptional maps of genes coding (A) adrenoceptors alpha 1; (B) 
adrenoceptors alpha 2; (C) adrenoceptors beta 1; (D) adrenoceptors beta 2. Gene expression data was obtained 
from the Allen Mouse Brain Atlas (AMBA) and measured using in situ hybridization. Transcriptional levels 
across a macroscopic cortical area were summarized and plotted as the mean ISH intensity across voxels of 
that brain area, or ‘expression energy’. 
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activation. We observe the strongest differences in two networks previously linked to LC activity in 
humans exposed to stress29: (1) the Salience Network (hyperconnectivity in agranular insular area, 
anterior cingulate, ventro-medial striatum, accumbens, globus pallidus, parafascicular nucleus of the 
thalamus and hippocampus; Figure 5A), and (2) the Amygdala Network (hyperconnectivity in 
basomedial and basolateral amygdala, claustrum, sub-thalamic nucleus and zona incerta; Figure 5B). 
Additionally, LC activation also increased connectivity within the Association/Auditory Network 
(Figure 5C), the Dorsal Hippocampus Network (Figure 5D), the Striato-Motor Network (Figure 5E), 
and the Antero-Posterior Retrosplenial / Default-Mode-Network (Figure 5F). These results suggest that 
LC activation expands the synchrony of signals in several large-scale networks, most significantly in 
the Salience and Amygdala Networks. These results are remarkably similar to those in humans, showing 
that acute stress increases FC within homologous salience/amygdala networks30,31 in a beta-adrenergic 




Network connectivity changes correlate with norepinephrine and dopamine turnover  
After completion of the two rs-fMRI sessions, mice were given one/two weeks to recover (see 
methods). Eight hM3Dq-mCh mice and five mCh controls were injected again with clozapine (0.03 
mg/kg, i.p.), and their brains were collected 90 minutes later to address two important issues; first, we 
wanted to ensure that clozapine exclusively activated noradrenergic LC neurons, and that activation 
occurred in all hM3Dq-mCh mice but not in the mCh controls. Second, we wanted to assess whether 
LC activation led to measurable NE release in target regions throughout the brain, and whether NE levels 
would correlate with observed changes in network connectivity. In order to address these two issues in 
each individual mouse, we pursued a two-pronged strategy for tissue processing (Figure 6A): Freshly 
Figure 5. Rapid changes in resting-state network connectivity after LC activation. 
Voxel-wise dual-regression analysis of revealed clusters of significant ‘group x time interactions’ in 6/13 
resting-state networks (p-value<0.05, TFCE corrected). A linear mixed model showed significant network 
strength increases in the hM3Dq-mCh group compared to mCh control mice, after clozapine injection. Bar 
plots represent mean ± SEM. *=p<0.05, **=p<0.01 (FDR corrected) 
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collected brains were split with a razorblade along the superior colliculus to collect one section 
containing the LC for immunohistochemistry, and a second section containing the forebrain. From the 
forebrain section, we rapidly dissected cerebral cortex, hippocampus and dorsal striatum on ice. Samples 
were snap frozen and processed for analysis of monoamines and their metabolites using reversed-phase 
ultra-high-performance liquid chromatography (uHPLC) coupled with electrochemical detection 
(Figure 6A).  
Co-labelling for TH and cFos revealed that clozapine injection only induced a strong and reliable 
activation of noradrenergic neurons in the LC of the hM3Dq-mCh mice (representative image in Figure 
6B, sections of all mice presented in Figure S7). This validates that LC activation was successful in the 
mice undergoing fMRI scans. In parallel, we used uHPLC to measure and quantify the monoaminergic 
neurotransmitters norepinephrine (NE), dopamine (DA) and serotonin (5HT), as well as their main 
metabolites 3-methoxy-4-hydroxyphenylglycol (MHPG, metabolite of NE), homovanillic acid (HVA, 
metabolite of DA), 3,4-dihydroxyphenylacetic acid (DOPAC, metabolite of DA), and 5-
hydroxyindoleacetic acid (5-HIAA, metabolite of 5HT). We were able to reliably detect and quantify 
all measured compounds (see representative chromatographs in Figure S8). NE levels decreased in all 
brain regions (Figure 6C), suggesting that LC activation for 90 minutes had depleted NE storage 
vesicles, as would be expected after sustained high-frequency firing. In agreement, MHPG levels 
increased in all brain regions (Figure 6D), resulting in a very strong increase in catabolic NE turnover 
(MHPG/NE, Figure 6E). Dopamine levels were not changed in any of the brain regions under 
investigation (Figure 6F), yet we observed a robust increase in both hippocampal HVA and DOPAC 
(Figure 6G, H), and a small but significant increase of HVA in the cortex (Figure 6G). Dopamine 
turnover ratios (HVA/DA and DOPAC/DA) were increased in the hippocampus but not in striatum or 
cortex (Figure 6I, J). These results are in line with recent evidence that LC neurons can release DA in 
certain brain regions including the hippocampus10,11,19,53. Our data newly suggest that DA release from 
LC neurons may be biased towards the hippocampus compared to the cortex and striatum. Epinephrine, 
5-HT and 5-HT turnover ratios were not altered in any of the brain regions sampled (Figure S9).  
As we performed fMRI and uHPLC analyses in the same mice (although with a temporal delay 
of 1 week and in response to separate injections with clozapine), we were able to conduct a correlation 
analysis between individual differences in neurotransmitter turnover and corresponding changes in 
network connectivity. We found positive correlations between the NE and DA turnover ratios in the 
cortex and changes in FC within the Salience Network (Figure 6K, Figure S10A), as well as between 
NE and DA turnover ratios in the hippocampus and FC in the Hippocampus Network (Figure 6L, 
Figure S10E). NE turnover in the striatum, but not DA turnover, correlated with FC changes in the 
Striato-Motor Network (Figure 6M, Figure S10C, F). Importantly, we observed no correlation between 
5-HT levels/turnover and the respective network connectivity changes in any of the brain regions tested 
(Figure S10G-I). These results collectively suggest that brain network changes we observe with rs-
fMRI are tied to the amount of NE and/or DA released in a given region. 
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LC neurons project sparsely to the dorsal striatum (caudate-putamen) 
Although increased NE turnover in the cortex and hippocampus was expected due to strong 
innervation by the LC, the increased NE turnover in the dorsal striatum (consisting of caudate and 
putamen)54 was surprising, because this region is widely thought to be devoid of NE projections24,46. In 
agreement with increased striatal NE turnover, we also observed a strong increase in the node 
modulation index (NMI) in the caudate-putamen (Figure 3E), and increased functional connectivity 
within the large-scale Striato-Motor Network (Figure 5E). Thus, we decided to first test whether we 
could detect noradrenergic axons within the caudate-putamen. We stained for the norepinephrine 
reuptake transporter Slc6a2 (NET), which is expressed exclusively in noradrenergic cells55,56. Although 
the caudate-putamen appears devoid of NET compared to the intense NET staining seen in the adjacent 
cortex (Figure 7A), we clearly detected long, thin axons in the caudate-putamen (Figure 7B). To 
investigate whether these axons originate from LC neurons, we delivered a retrograde AAV2 virus57 
carrying floxed mCherry into the dorsolateral caudate-putamen of DBH-iCre mice. Seven weeks after 
virus injection, we stained the LC and detected a clearly recognizable subset of LC neurons that 
expressed mCherry in transgenic animals (n=3) but not in wild-type controls (n=1) (representative 
images from each animal shown in Figure 7C and Figure S11). We were able to reproduce these 
findings with a second Cre-dependent retrograde AAV2 virus that expresses EGFP (Figure 7D), which 
also allowed us to detect axons in the caudate-putamen that were co-labelled with both EGFP and NET 
(Figure 7E). Together, these data show that there are sparse projections from LC to the caudate-
putamen. These projections could account for the increase in NE levels detected in the striatum after LC 
stimulation, as well as for the increased functional connectivity observed in the caudate-putamen and in 









Figure 6. NE and DA turnover induced by LC activation correlates with rs-fMRI data. (A) Outline of the 
tissue collection strategy following completion of fMRI scans. (CTX: cortex, HC: hippocampus, STR: striatum 
= caudate putamen) (B) Representative images of cFos expression in the LC after clozapine injection in hM3Dq-
mCh or mCh mice. All scale bars: 50 μm. (C-J) Levels of monoaminergic neurotransmitters and their 
metabolites in the cortex, hippocampus and striatum. NE was reduced in all brain regions of hM3Dq-mCh mice 
relative to mCh controls (C: main effect of group: F(1,33)=42.48, p<0.0001), MHPG was increased (D: main 
effect of group F(1,33)=121.80, p<0.0001) and NE turnover ratio (MHPG/NE) was increased (E: main effect of 
group: F(1,33)=291.50, p<0.0001; two-way ANOVA with Sidak post hoc tests). Although there was no 
difference in the levels of DA (F: main effect for group F(1,33)=0.81, p=0.3748), its metabolite HVA was 
increased in the cortex and the hippocampus in hM3Dq-mCh mice (G: significant main effect for group 
F(1,11)=11.60, p=0.0059) and DOPAC was increased only in the hippocampus (H: significant main effect for 
group F(1,33)=22.13, p<0.0001;). The DA turnover ratios were only increased in the hippocampus, for both 
HVA/DA (I: main effect of group: F(1,33)=8.91, p=0.0053), and DOPAC/DA (J: main effect of group: 
F(1,33)=19.81, p<0.0001), two-way ANOVA with Sidak post hoc tests). (K-M) Correlation between FC 
changes and neurotransmitter levels in the cortex (K), in the hippocampus (L), and in the striatum (M). Circles 
correspond to mCh mice, filled circles to hM3Dq-mCh mice. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
Data represent mean ± SEM.  
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Figure 7. The dorsal striatum (caudate-putamen) is innervated by the LC. (A) Immunohistochemical 
localization of the norepinephrine transporter (NET) reveals noradrenergic axons in the caudate-putamen 
(arrows). (B) Magnification of the box in (A) showing NET+ axons (arrows). (C) A retro-AAV2 that 
expresses Cre-dependent mCherry was delivered to the dorsolateral caudate-putamen and resulted in 
mCherry+ neurons in the LC of DBH-iCre (n=3), but not wild type (n=1) mice (representative pictures from 
one animal shown, additional images for all mice in Figure S11). (D) Stereotactic delivery of a Cre-
dependent retro-AAV2 virus expressing EGFP in the dorsolateral caudate-putamen resulted in EGFP+ LC 
neurons in a DBH-iCre mouse, but not in a wild type mouse. (E) Magnification of the box in (D) showing 
the axonal co-localization of NET and EGFP in the caudate putamen of a DBH-iCre animal. CTX=cortex; 
STR=striatum 
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DISCUSSION 
 
Revealing the connectomic fingerprint of norepinephrine release after LC activation 
Neuromodulatory systems of the brain track and integrate environmental signals, exert powerful 
control over neuronal function, and are the primary targets of most neuropsychiatric treatment 
strategies58–60. It is, however, challenging to study the impact of an individual neuromodulatory system 
across large-scale neuronal networks. The advent of optogenetics and chemogenetics, combined with 
advances in rodent imaging capabilities, now enables us to link circuit-level manipulations to global 
network changes. Recent studies have used these approaches to show that selective manipulation of 
dopamine61,62 and serotonin63 release can lead to global activity changes measured by fMRI. Our work 
extends these studies by assessing the role of the LC-NE system in assembling and rearranging 
connectivity within and between well-defined large-scale neuronal systems using rs-fMRI. This task-
free, system level approach allows interrogation of different functional circuits in parallel (i.e. the 
connectome), and is therefore well-suited for testing the concept that changes in neuromodulator levels 
can shift neural ‘brain states’. Further, rs-fMRI is emerging as a tool for translational neuroscience, as 
it can be performed in multiple species:  humans22, primates64, and rodents65. However, clinical studies 
using rs-fMRI often do not translate well into useful diagnostic or prognostic information for individual 
patients66, in part because it is unclear how molecular and/or cellular defects are reflected by changes in 
connectivity at the network level. Our novel chemo-connectomic approach attempts to bridge this gap 
by leveraging the full power of genetic and molecular tools available in mice. Additionally, it establishes 
the framework necessary to link the activity of neuromodulatory systems to clinically relevant brain 
signals and their neuroanatomical substrates.  
 
Adrenoceptor distribution as an organizing principle affording "global specificity" 
Neurons in the LC are topographically organized based on their widespread efferent 
projections46,47, and circuit-based approaches reveal functional specificity of sub-populations of LC 
neurons based on their target projection regions5,12–16,18,19,67,68. LC neurons appear to form neuronal 
ensembles, which can be activated in response to isolated sensory stimuli67,69. With increasing stimulus 
strength, more LC-ensembles can be activated, leading to "global" LC activation in response to strong 
stimuli (such as stress exposure)69. Widespread NE release in response to this global LC activation is 
commonly thought to act as a broadcast signal, which modulates brain states, gearing specific networks 
towards integrating environmental information, allowing to select/trigger adequate behaviors1,12,47. 
However, it remains unclear how such a global signal can achieve network-wide specificity (e.g. to 
interrupt ongoing behavior and trigger an orienting response). The widespread projections of the LC 
make it unlikely that the anatomical connections of these afferents encode this specificity47. In line with 
this assumption, a study using manganese-enhanced MRI suggested that the anatomy of LC projections 
alone does not predict functional connectivity70. However, NE release in projection regions can be 
mediated by adrenoceptor distribution. This was, for example, shown in the basal forebrain, where 
alpha-1 and beta-1 adrenoceptors are expressed on cholinergic neurons, whereas alpha-2 receptors 
reside on GABAergic interneurons. Thus, NE release can simultaneously activate cholinergic neurons 
and inhibit GABAergic neurons71,72. To address the potential modulatory role of adrenoceptors in the 
effects of global LC activation, we correlated brain-wide changes in functional connectivity (FC) with 
gene expression density of adrenergic, dopaminergic and serotonergic receptors. We observed strong 
correlations between FC and expression levels of alpha-1 and beta-1 adrenoceptors, which are known 
to have low binding affinity for NE and are thus only activated in response to high levels of NE 
release24,26. A weaker correlation was also found for inhibitory alpha-2 receptors. The absence of a 
correlation with beta-2 adrenergic receptors was unexpected, given that both beta-1 and beta-2 
adrenoceptors are ubiquitously expressed and have similar binding affinity for NE73, although 
contrasting effects of beta-1 and beta-2 receptors on working memory performance have previously 
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been reported74,75. To the best of our knowledge, our results are the first to demonstrate a role for 
adrenergic receptor distribution in providing specificity to global NE release on a brain-wide, functional 
level. This helps to explain how a "global broadcast" signal can achieve highly specific functional and 
behavioral effects. Molecular neuroscience tools in mice are rapidly advancing, for example recent work 
has conducted careful input-output tracing of LC connectivity using novel trans-synaptic tracing tools76, 
and refined sequencing approaches have begun to genetically track LC projections across the mouse 
cortex77. As these and similar datasets become catalogued and readily accessible, our rs-fMRI data can 
serve as a resource to map functional, brain-wide connectome data onto the molecular characteristics of 
the LC-NE system. 
 
LC activation recapitulates many of the complex effects triggered by stress exposure 
Modern theories of LC function propose that LC activation serves to optimize the trade-off 
between exploitation and exploration, with strong, global LC activity causing interruption of ongoing 
activity to enable the selection of appropriate behaviors20. Global LC activity is robustly triggered by 
noxious/stressful stimuli12,13,24,25,67,78, which induce anxiety and reduce exploratory activity, through 
circuits involving the amygdala and prefrontal cortex3,13–16. Our DREADD-induced activation of the LC 
similarly reduces exploratory activity and increases anxiety, and globally induces cFos expression 
throughout the LC. Therefore, our global LC activation likely resembles peak LC activity that would 
normally be triggered by stressful stimuli.  
Our data are well in line with findings in humans where acute stress exposures (induced by 
aversive movies or social stressors) were followed by a significant increase of FC in the Salience 
Network30 and Default Mode Network79. Similarly, task-based fMRI reveals that acute stress leads to 
increased interconnectivity and positive BOLD responses within several cortical regions related to 
salience processing (frontoinsular, anterior cingulate, inferotemporal, and temporoparietal) and 
subcortical regions (amygdala, striatum, thalamus, hypothalamus, hippocampus and midbrain) as a 
function of stress response magnitude31,80–82. Notably, increased connectivity in the Salience Network 
was blocked by systemic administration of a beta-adrenergic receptor antagonist (propranolol)31. Given 
that LC activation is only one aspect of the highly complex changes observed during an acute stress 
response83, and considering that our analyses were performed in lightly anesthetized mice, it is 
remarkable that our results for the Salience Network, the Amygdala Network, and also the Default-
Mode Network closely resemble fMRI and rs-fMRI findings described after acute stress exposures in 
humans29,82 (Figure 5). Since our model allowed us to selectively and directly manipulate LC activity 
with DREADDs, our results causally show that selective LC activation rapidly reorganizes functional 
connectivity within specific large-scale networks.  
Long-lasting hyperactivity of the LC is often observed after severe or chronic stress 
exposures78,84 and is considered a hallmark feature of post-traumatic stress disorder (PTSD)4,85. Two 
recent rs-fMRI studies showed - in both rats and mice - that chronic stress exposure resulted in large-
range increases in functional network connectivity for regions including prelimbic/infralimbic areas, 
amygdala, cingulate cortex and hippocampus86,87. In PTSD patients, fMRI reveals network wide changes 
in the amygdala, insula, hippocampus and anterior cingulate cortex88,89. Therefore, the changes observed 
after chronic stress exposure in rodents and in PTSD patients are strikingly similar to the effects of 
selective LC stimulation. Hyperactivity of the LC represents only one aspect of the multifaceted changes 
occurring in stress-related pathologies, but our data provide additional evidence that modulating LC 
activity might be a promising therapeutic approach78,90.  
 
Functional connectivity after LC activation involves dopamine release and dopamine receptors 
Several recent reports have shown that dopamine (DA) can be co-released from LC terminals in 
the hippocampus10,11,53 and thalamus19. We also detect a strong increase in DA turnover in the 
hippocampus, and a subtle increase in the cortex (with no effects in the striatum). Our cortex samples 
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contained heterogeneous regions, it is likely that specific cortical subregions (e.g. mPFC) display 
stronger changes in DA turnover, similar to the effects observed in the hippocampus. In concordance 
with our data, previous microdialysis experiments have detected release of both DA and NE in the 
medial prefrontal cortex after chemical or electrical activation of the LC, while the same stimulations 
increased NE but not DA in the nucleus accumbens and caudate nucleus91–93. In agreement with this 
regional specificity of NE and DA release, our study reveals positive correlations between cortical DA 
turnover and FC within the Salience Network, as well as between hippocampal DA turnover and FC 
within the Hippocampus Network. In contrast, no significant correlations were detected in the striatum. 
Furthermore, brain-wide changes in FC induced by LC stimulation correlated positively with the 
transcript expression levels of D1, D3 and D4 dopamine receptors. Together, these data provide new 
evidence for a physiologically relevant, regionally restricted role of DA release in response to LC 
stimulation. Future studies will have to test whether all LC neurons (or only selected sub-populations 
with specific projection targets) are able to release DA, and if specific interactions at the projection site 
are required to enable DA release. Finally, it remains unclear whether this co-release occurs under 
physiological conditions, as evidence suggests that it depends on the firing rate of individual LC 
neurons93.  
 
LC-induced synchronization in the dorsal striatum (caudate-putamen) 
Although close interactions between dopaminergic and noradrenergic systems have long been 
recognized94, the dorsal striatum (caudate-putamen) is widely thought to be devoid of noradrenergic 
projections24,46, and indeed staining for the NE transporter (NET, Figure 7A) or DBH95 shows a strong 
depletion in the caudate-putamen. Given these data, we were surprised when our connectome analysis 
revealed that LC activation strongly increased the strength of connectivity of the caudate-putamen 
(Figure 3C). Further, we observed synchronization of rs-fMRI activity in the Striato-Motor Network, 
which positively correlated with increased NE turnover in the same region (Figure 6M). Indeed, several 
studies have shown fairly high levels of NE96 in the caudate-putamen, as well as extracellular striatal 
NE increase after mild stress (handling)97 or LC stimulation92. Adrenergic alpha-1, alpha-2 and beta-1 
receptors are abundantly expressed on striatal pre- and post-synaptic membranes and cell bodies98–102, 
and beta-adrenergic receptor binding density is very high in the caudate-putamen of rodents and 
humans103–105. Our results show that a considerable number of LC neurons directly project to the caudate-
putamen, which is in line with early retrograde tracing work106 but was rarely recognized in more recent 
literature. Taken together, the fact that the caudate-putamen expresses high levels of adrenoceptors, is 
sparsely innervated by LC neurons, and contains increased NE levels after LC stimulation, suggests that 
the strong increase of functional connectivity in the caudate-putamen after LC stimulation is driven by 
direct projections from the LC. These findings may be relevant for Parkinson's disease, where an 
involvement of the LC-NE system is increasingly being recognized8,107. 
 
Conclusions 
Using the novel chemo-connectomics approach presented here, we provide the first brain-wide 
analysis of connectome reconfiguration in response to selective LC activation. We show a profound, 
rapid and specific activation of large-scale networks related to salience processing, which occurs within 
minutes after clozapine administration specifically in mice expressing DREADDs. These effects are 
observed similarly in each hemisphere and they are blocked by activating presynaptic, auto-inhibitory 
alpha-2 adrenoceptors. Shifts in large-scale network connectivity correlate spatially with the distribution 
of adrenergic and dopaminergic receptor levels and with (post-mortem) measurements of NE, DA, and 
their metabolites in a within-subject design. These network effects are accompanied by increased pupil 
size and heightened anxiety, suggesting that the observed changes in brain network organization 
ultimately serve to promote vigilance and threat detection.  
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Methods 
 
Mice. C57Bl/6J male mice (2 months old) were obtained from Janvier (France). Heterozygous 
C57BL/6-Tg(Dbh-icre)1Gsc mice33 were generously provided by Prof. Günther Schütz and kept in 
breeding trios with wild-type C57Bl/6J mice at the ETH Zurich animal facility (EPIC). Mice were 
maintained in IVC cages with food and water ad libitum, in a temperature- and humidity-controlled 
facility on a 12-hour reversed light-dark cycle (lights off: 8:15am; lights on: 8:15pm). The experimenters 
were blinded to the DREADD groups for all experiments. All experiments were performed in 
accordance with the Swiss federal guidelines for the use of animals in research, and under licensing 
from the Zürich Cantonal veterinary office.  
 
Outlier Removal. All mice (hM3Dq-mCh n=11; mCh n=8) successfully completed both fMRI sessions. 
However, due to a fault in the ventilation system that artificially supports breathing after the MRI, three 
animals died after the second session (hM3Dq-mCh n=2; mCh n=1). For all the others, the time until 
conscious intention to move was 10.6±4 minutes. One animal (mCh group) was excluded from the rs-
fMRI analysis because the preparation time exceeded 30 minutes (average time between anesthesia 
induction and start of the MRI scanning, including intubation and cannulation was 12.8±3 minutes). In 
the weeks between the second fMRI session and tissue collection for molecular analyses, 2 mice were 
found dead in their cage (n=1 from hM3Dq-mCh, and n=1 from mCh groups). Otherwise, no mice were 
excluded from any of the experiments. 
 
Stereotaxic brain injections. Viral vectors and viral vector plasmids were designed and produced by 
the Viral Vector Facility (VVF) of the Neuroscience Center Zurich. The viruses used had a physical titer 
of 6.0-6.5 x 1012 vg/ml. For virus delivery, 2 to 3 month old mice were subjected to stereotactic brain 
injections. The mice were anesthetized with isoflurane and placed in a stereotaxic frame. For analgesia, 
animals received a subcutaneous injection of 2mg/kg Meloxicam and a local anesthetic (Emla cream; 
5% lidocaine, 5% prilocaine) before and after surgery. A pneumatic injector (Narishige, IM-11-2) and 
calibrated microcapillaries (Sigma-Aldrich, P0549) were used to inject 1 μL of virus (either ssAAV-
5/2-hSyn1-dlox-hM3D(Gq)_mCherry(rev)-dlox-WPRE-hGHp(A) or ssAAV-5/2-hSyn1-dlox-
mCherry(rev)-dlox-WPRE-hGHp(A)) bilaterally into the locus coeruleus (coordinates from bregma: 
anterior/posterior -5.4 mm, medial/lateral +/-1.0 mm, dorsal/ventral -3.8 mm). For the retrograde AAV2 
injection, 0.8 μL of ssAAV-retro/2-hEF1α-dlox-hChR2(H134R)_mCherry(rev)-dlox-WPRE-hGHp(A) 
or  ssAAV-retro/2-hEF1a-dlox-EGFP(rev)-dlox-WPRE-bGHp(A) was delivered bilaterally  to the 
dorsolateral site of the caudate-putamen (from bregma: anterior/posterior 0.86 mm, medial/lateral +/-
1.8 mm, dorsal/ventral -3.2 mm). The health of the animals was evaluated by post-operative checks over 
the course of 3 consecutive days. Brain illustrations were created with the Scalable Brain Atlas50,108. 
 
Pupillometry. For pupil recordings we used a Raspberry Pi NoIR Camera Module V2 night vision 
camera, an infrared light source (Pi Supply Bright Pi - Bright White and IR camera light for Raspberry 
Pi) and a Raspberry Pi 3 Model B (Raspberry Pi Foundation, UK). Animals were anesthetized with 
isoflurane (4% induction, 1.5% maintenance), then an intraperitoneal catheter delivering PBS was 
placed and the video recording was initiated. After 2 minutes of baseline recording, 0.03 mg/kg 
clozapine (Sigma-Aldrich, Steinheim, Germany) was injected through the catheter and the video 
recording continued for another 8 minutes. Pupil diameter was measured using a custom MATLAB 
(MathWorks, Natick, MA, USA) script. Frames were binarized and an ellipse-fitting algorithm was used 
to approximate the pupil size. Measurements after clozapine injection were then normalized to baseline 
(measurements before clozapine).  
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Open field test (OFT). Open-field testing took place inside sound insulated, ventilated multi-
conditioning chambers (TSE Systems Ltd, Germany). The open field arena (45 cm (l) x 45 cm (w) x 40 
cm (h)) consisted of four transparent Plexiglas walls and a light grey PVC floor. For all experiments, 
mice were tested under dim lighting (4 Lux across the floor of the open field, provided by four equally 
spaced yellow overhead lights) with 75-77 dB of white noise playing through the speakers of each box, 
as described previously39. The room housing the multi-conditioning chambers was illuminated with red 
LED lights (637 nm). Animals were injected i.p. with 0.03 mg/kg clozapine (Sigma-Aldrich, Steinheim, 
Germany) and placed directly into the center of the open field. Tracking/recording was initiated upon 
first locomotion grid beam break, lasted for 30 minutes and was analyzed in 3-minute bins. 
 
Tissue preparation, antibodies and immunohistochemistry. For experiments where brain tissue was 
collected exclusively for immunohistochemistry, mice were deeply anesthetized with pentobarbital (150 
mg/kg, i.p.) and perfused intracardially through the left ventricle for 2 minutes, with approximately 20 
mL ice-cold PBS (pH 7.4). The brain was dissected, blocked and fixed for 2-3 hrs in ice-cold 
paraformaldehyde solution (4% PFA in PBS, pH 7.4). The tissue was rinsed with PBS and stored in a 
sucrose solution (30% sucrose in PBS) at 4°C, overnight. Then the tissue was frozen in tissue mounting 
medium (Tissue-Tek O.C.T Compound, Sakura Finetek Europe B.V., Netherlands), and sectioned 
coronally using a cryostat (Leica CM3050 S, Leica Biosystems Nussloch GmbH) into 40 μm thick 
sections. The sections were immediately transferred into ice-cold PBS and stored at -20°C.  
For immunohistochemistry, brain sections were submerged in primary antibody solution containing 
0.2% Triton X-100, and 2% normal goat serum in PBS, and were incubated at 4ºC under continuous 
agitation over 2 nights. Then the sections were washed 3 times in PBS for 10 minutes/wash, and 
transferred in secondary antibody solution containing 2% normal goat serum in PBS. After 3 more PBS 
washes, the sections were mounted onto glass slides (Menzel-Gläser SUPERFROST PLUS, Thermo 
Scientific), air-dried and coverslipped with Dako fluorescence mounting medium (Agilent 
Technologies). The primary antibodies used were: rabbit anti-mCherry (ab167453, Abcam, 1:1000), 
mouse anti-TH (22941, Immunostar, 1:1000), rabbit anti-cFos (226 003, Synaptic Systems, 1:5000), 
mouse anti-NET (NBP1-28665, Novus Biologicals, 1:1000), chicken anti-GFP (ab13970, Abcam. 
1:1000). The secondary antibodies used were: goat anti-rabbit Alexa 546 (A11035, Life Technologies, 
1:300), goat anti-mouse Alexa 488 (ab150113, Abcam, 1:300), goat anti-mouse Cy3 (115-165-003, 
Jackson ImmunoResearch, 1:300), goat anti-rabbit Alexa Fluor 488 (A-11008, Thermo Fisher Scientific, 
1:500), goat anti-chicken (A-11039, Thermo Fischer Scientific, 1:1000) and Nissl stain (N21483, 
NeuroTrace 640/660 Nissl stain, Molecular probes).  
Microscopy images were acquired in a confocal laser-scanning microscope (CLSM 880, Carl Zeiss AG, 
Germany), maintaining a pinhole aperture of 1.0 Airy Unit and image size 1024x1024 pixels. Images of 
LC were acquired using a Z-stack with a 20x objective and pixel size 0.59 μm. Images of the caudate 
putamen and the whole brain (sagittal plane) were acquired with the 20x (pixel size 0.59 μm) and the 
10x (pixel size 1.19 μm) objective respectively, using a Z-stack and tiles. Images of axons were acquired 
with the 20x (pixel size 0.59 μm) or the 40x (pixel size 0.35 μm) objective.  
 
Tissue collection for uHPLC and immunohistochemistry. When brain tissue was collected for both 
uHPLC and immunohistochemistry, mice were rapidly euthanized by cervical dislocation. The brain 
was first divided into anterior and posterior with a single cut from a razorblade at the beginning of the 
cerebellum as shown in Figure 5A. The cortex (overlying the hippocampus), hippocampus and striatum 
were immediately dissected on an ice-cold glass surface, snap-frozen in liquid nitrogen and stored at -
80°C until further processing for uHPLC. The posterior part including the locus coeruleus was fixed in 
4% PFA for 2 hours, cryoprotected in a sucrose solution and frozen in mounting medium as described 
above for immunohistochemistry.   
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MRI. Data acquisition was performed on a Biospec 70/16 small animal MR system (Bruker BioSpin 
MRI, Ettlingen, Germany) equipped with a cryogenic quadrature surface coil for signal detection 
(Bruker BioSpin AG, Fällanden, Switzerland). Standard adjustments included the calibration of the 
reference frequency power and the shim gradients using MapShim (Paravision v6.1). For anatomical 
assessment, a T2-weighted image is acquired (FLASH sequence, in-plane resolution of 0.05 × 0.02 mm, 
TE = 3.51, TR = 522ms). For functional connectivity acquisition, a standard gradient-echo echo planar 
imaging sequence (GE-EPI, repetition time TR=1s, echo time TE=15ms, in-plane resolution 
RES=0.22×0.2mm2, number of slice NS=20, slice thickness ST=0.4 mm, slice gap=0.1mm) was applied 
to acquire 2280 volumes in 38 min. After 15 minutes of GE-EPI acquisition, a bolus of 0.03 mg/kg 
clozapine was intravenously injected to activate DREADDs. 
 
Anaesthesia. The levels of anaesthesia and physiological parameters were monitored to obtain a reliable 
measurement of functional connectivity following established protocols44,109. Briefly, anaesthesia was 
induced with 4% isoflurane and the animals were endotracheally intubated and the tail vein cannulated. 
Mice were positioned on a MRI-compatible cradle, and artificially ventilated at 80 breaths per minute, 
1:4 O2 to air ratio, and 1.8 ml/h flow (CWE, Ardmore, USA). A bolus injection of muscle relaxant 
(pancuronium bromide, 0.2 mg/kg) was administered, and isoflurane was reduced to 1%. Throughout 
the experiment, mice received a continuous infusion of pancuronium bromide 0.4 mg/kg/h. Body 
temperature was monitored using a rectal thermometer probe, and maintained at 36.5 °C ± 0.5 during 
the measurements. The preparation of the animals did not exceed 15 minutes. In an additional 
experiment, mice were pre-treated with a bolus injection of medetomidine 0.05 mg/kg, followed by a 
continuous infusion at 0.1 mg/kg/h. 
 
Resting-state fMRI data pre-processing and analysis. Resting state fMRI datasets were de-spiked 
and artefacts were removed using an existing automated pipeline, adapted for the mouse109. This 
procedure includes ICA-based artefact removal, motion correction and regression. Thereafter, data sets 
were band-pass filtered (0.01-0.25 Hz), skull-stripped and normalized to the Allen Brain Institute 
reference atlas (http://mouse.brain-map.org/static/atlas) using ANTs v2.1 (picsl.upenn.edu/ANTS).  
Two types of analyses were performed on this data to compare the influence of LC activation on 
functional connectivity; first, we employed an exploratory and data-driven connectome analysis to 
describe the temporal and spatial changes at the whole-brain level. Briefly, BOLD time series are 
extracted using a subset of ROIs from the Allen’s Common Coordinate Framework (V3, 
http://help.brain-map.org/download/attachments/2818169/MouseCCF.pdf), which consisted of 165 
ROIs from isocortex, hippocampal formation, cortical subplate, striatum, pallidum, thalamus, 
hypothalamus, hindbrain and midbrain (full list available in supplementary material, table 1). 
Connectivity couplings between all ROIs are measured using a regularized Pearson’s correlation 
coefficient implemented in FSLNets, using  sliding time windows of either 1 minute (Figure 2) or 15 
minutes (Figure 3). For each block, the resulting connectome matrices are fed into a nonparametric 
permutation testing with 5000 permutations to detect differences between groups, corrected for multiple 
comparisons with Network Based Statistics (NBS). 
In our second analyses, we focused on changes in spatial patterns of correlated activity, also called 
resting-state networks (RSNs). We selected 15 meaningful RSNs from an independent cohort of n=15 
mice. Please note that the motor network, the striatum network and the striato-motor network are highly 
correlated, thus we considered only the latter for the analysis and reduced the number of RSNs to 13. 
We performed a dual regression approach110 as described by52. With this approach, we derived an index 
of coupling strength (i.e. temporal synchronicity) of the voxels within each RSN, by averaging the Z-
scores from the group-mean RSNs masks (thresholded at the 75th percentile). Group level statistics were 
performed in SPSS v22 using a Linear Mixed-Model, with the fixed factors DREADD-Group and Time 
(2-levels, repeated measure), and with the individual mice as the random factor. Corresponding contrasts 
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were used for post-hoc pairwise comparisons (LSD). P-values were considered significant at p<0.05 
after False Discovery Rate (FDR) correction for multiple comparisons between RSNs.  
 
Ultra-high performance liquid chromatography (uHPLC). To quantify norepinephrinergic (NE; 
epinephrine; MHPG), dopaminergic (DA; DOPAC; HVA), and serotonergic (5-HT; 5-HIAA) 
compounds, a reversed-phase uHPLC system coupled with electrochemical detection (RP-uHPLC-
ECD) was used (AlexysTM Neurotransmitter Analyzer, Antec Leyden, Zoeterwoude, Netherlands). In 
short, our previously validated RP-HPLC method with ion pairing chromatography was applied as 
described111, albeit with minor modifications regarding the installed column (BEH C18 Waters column, 
150 mm x 1mm, 1.7µm particle size) and pump preference (LC110S pump, 497 bar; flow rate of 
68µL/min), achieving the most optimal separation conditions in a RP-uHPLC setting. Levels of the 
monoamines and metabolites were calculated using Clarity softwareTM (DataApex Ltd., v6.2.0.208, 
2015, Prague, Czech Republic).  
Brain samples were defrosted to 4 °C and subsequently homogenized in cold 800μl sample buffer (50 
mM citric acid, 50 mM phosphoric acid, 0.1 mM EDTA, 8 mM KCl and 1.8 mM octane-1-sulfonic acid 
sodium salt (OSA), adjusted to pH = 3.6), using a Bio-Gen PRO200 homogenizer (PRO Scientific Inc., 
Oxford, CT, USA; 60 s, 4°C). To remove excess proteins, 450 μl homogenate was transferred onto a 
10,000 Da Amicon® Ultra 0.5 Centrifugal Filter (Millipore, Ireland) that had been pre-washed twice 
using 450μl sample buffer (centrifugation: 14,000 × g, 20 min, 4 °C). The Amicon® filter loaded with 
the homogenate was then centrifuged (14,000 × g, 20 min, 4°C). Finally, the filtrate was transferred into 
a polypropylene vial (0.3mL, Machery-Nagel GmbH & Co. KG, Germany) and automatically injected 
into the previously-mentioned uHPLC column by the Alexys™ AS110 sample injector. 
 
Statistics for behavior, pupillometry, immunohistochemistry and uHPLC. GraphPad Prism 8.0 was 
used for statistical analyses. We used independent samples t-tests when comparing two independent 
groups, and paired-samples t-tests when comparing the same group twice. When comparing more than 
two groups, we used one-way ANOVAs if there was a single independent variable, or two-way 
ANOVAs for two-factorial designs (e.g. region x treatment). Significant main effects and interactions 
were analyzed using Sidak's post hoc tests. 
 
Gene expression. Gene expression data was obtained from the Allen Mouse Brain Atlas (AMBA)50 
using the Allen Software Development Kit (SDK, stnava.github.io/ANTs/)112. Gene expression data in 
the AMBA is measured using in situ hybridization from: (i) sagittal section experiments with high 
genome coverage, and (ii) coronal section replications for approximately 3500 genes with 
restricted expression patterns in the brain (11). Transcriptional levels across a macroscopic cortical area 
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